bioAffinity Technologies, Inc. (BIAF) NASDAQ
1.68
-0.07(-4.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.03M |
| Enterprise Value | -3.26M |
| P/E Ratio | -0.48 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 1.35 |
| Price/Book Ratio | 2.06 |
| Enterprise/Revenue | 1.04 |
| Enterprise/EBITDA | -0.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.81 |
| Operating Margin | -2.04 |
Management Effectiveness
| Return On Assets | -2 |
| Return On Equity | -3.59 |
Income Statement
| Revenue | 6.16M |
| Revenue/Share | 1.26 |
| Gross Profit | 1.43M |
| EBITDA | -10.07M |
| Net Income | -14.91M |
| Diluted EPS | -8.66 |
Balance Sheet
| Total Cash | 3.1M |
| Total Cash/Share | 0.69 |
| Total Debt | 1.38M |
| Total Debt/Equity | 0.38 |
| Current Ratio | 1.36 |
| Book Value Per Share | 0.81 |
Price History
| 52-Week Change | -78.68 |
| 52-Week High | 13.8 |
| 52-Week Low | 0.69 |
| Moving Average 50 Days | 2.67 |
| Moving Average 200 Days | 2.74 |
Statistics
| Average Volume | 8.61M |
| Shares Outstanding | 4.53M |
| % Held by Institutions | 5.39 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | September 19, 2025 |
